In conclusion, we developed a nomogram model constructed with LI-RADS features, quantitative contrast-enhanced MRI parameters, and clinical indicators that can accurately and conveniently and noninvasively predict the expression of GPC-3 in HCC patients. This evidence concerns the gene GPC3 and hepatocellular carcinoma.